Johnson & Johnson (JNJ) Accumulated Expenses (2009 - 2026)

Johnson & Johnson (JNJ) has 18 years of Accumulated Expenses data on file, last reported at $7.4 billion in Q1 2026.

• Quarterly Accumulated Expenses rose 190.04% year-over-year to $7.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.4 billion (up 190.04% YoY) and the FY2025 annual result came in at $8.6 billion, up 108.29% from the prior year.
• Accumulated Expenses retreated to $7.4 billion in Q1 2026 per JNJ's latest filing, from $8.6 billion in the prior quarter.
• The five-year high for Accumulated Expenses was $13.0 billion in Q2 2022, with the low at $2.6 billion in Q1 2025.
• Average Accumulated Expenses over 5 years is $7.4 billion, with a median of $7.0 billion recorded in 2024.
• Year-over-year, Accumulated Expenses soared 531.36% in 2022 and sank 63.66% in 2025.
• Johnson & Johnson's Accumulated Expenses stood at $12.0 billion in 2022, then sank by 66.59% to $4.0 billion in 2023, then rose by 3.33% to $4.1 billion in 2024, then surged by 108.29% to $8.6 billion in 2025, then slipped by 13.91% to $7.4 billion in 2026.
• Business Quant data shows JNJ's Accumulated Expenses at $7.4 billion in Q1 2026, $8.6 billion in Q4 2025, and $6.9 billion in Q3 2025.